These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23750482)

  • 21. Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing.
    Takano S; Tian W; Matsuda M; Yamamoto T; Ishikawa E; Kaneko MK; Yamazaki K; Kato Y; Matsumura A
    Brain Tumor Pathol; 2011 Apr; 28(2):115-23. PubMed ID: 21344322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel COLD-PCR/FMCA assay enhances the detection of low-abundance IDH1 mutations in gliomas.
    Pang B; Durso MB; Hamilton RL; Nikiforova MN
    Diagn Mol Pathol; 2013 Mar; 22(1):28-34. PubMed ID: 23370430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo.
    Pusch S; Krausert S; Fischer V; Balss J; Ott M; Schrimpf D; Capper D; Sahm F; Eisel J; Beck AC; Jugold M; Eichwald V; Kaulfuss S; Panknin O; Rehwinkel H; Zimmermann K; Hillig RC; Guenther J; Toschi L; Neuhaus R; Haegebart A; Hess-Stumpp H; Bauser M; Wick W; Unterberg A; Herold-Mende C; Platten M; von Deimling A
    Acta Neuropathol; 2017 Apr; 133(4):629-644. PubMed ID: 28124097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isocitrate dehydrogenase 2 mutation is a frequent event in osteosarcoma detected by a multi-specific monoclonal antibody MsMab-1.
    Liu X; Kato Y; Kaneko MK; Sugawara M; Ogasawara S; Tsujimoto Y; Naganuma Y; Yamakawa M; Tsuchiya T; Takagi M
    Cancer Med; 2013 Dec; 2(6):803-14. PubMed ID: 24403254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IDH1 immunohistochemistry reactivity and mosaic IDH1 or IDH2 somatic mutations in pediatric sporadic enchondroma and enchondromatosis.
    Saiji E; Pause FG; Lascombes P; Cerato Biderbost C; Marq NL; Berczy M; Merlini L; Rougemont AL
    Virchows Arch; 2019 Nov; 475(5):625-636. PubMed ID: 31240473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A vaccine targeting mutant IDH1 induces antitumour immunity.
    Schumacher T; Bunse L; Pusch S; Sahm F; Wiestler B; Quandt J; Menn O; Osswald M; Oezen I; Ott M; Keil M; Balß J; Rauschenbach K; Grabowska AK; Vogler I; Diekmann J; Trautwein N; Eichmüller SB; Okun J; Stevanović S; Riemer AB; Sahin U; Friese MA; Beckhove P; von Deimling A; Wick W; Platten M
    Nature; 2014 Aug; 512(7514):324-7. PubMed ID: 25043048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. R132 mutations in canine isocitrate dehydrogenase 1 (IDH1) lead to functional changes.
    Kawakami S; Ochiai K; Azakami D; Kato Y; Michishita M; Morimatsu M; Ishiguro-Oonuma T; Onozawa E; Watanabe M; Omi T
    Vet Res Commun; 2018 Mar; 42(1):49-56. PubMed ID: 29285579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of Anti-Human ATRX Monoclonal Antibody AMab-6.
    Ogasawara S; Fujii Y; Kaneko MK; Oki H; Sabit H; Nakada M; Suzuki H; Ichimura K; Komori T; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2016 Oct; 35(5):254-258. PubMed ID: 27788029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis for multi-specific peptide recognition by the anti-IDH1/2 monoclonal antibody, MsMab-1.
    Kitago Y; Kaneko MK; Ogasawara S; Kato Y; Takagi J
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1274-9. PubMed ID: 27553275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of immunohistochemistry, DNA sequencing and allele-specific PCR for the detection of IDH1 mutations in gliomas.
    Loussouarn D; Le Loupp AG; Frenel JS; Leclair F; Von Deimling A; Aumont M; Martin S; Campone M; Denis MG
    Int J Oncol; 2012 Jun; 40(6):2058-62. PubMed ID: 22447191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitor potency varies widely among tumor-relevant human isocitrate dehydrogenase 1 mutants.
    Avellaneda Matteo D; Wells GA; Luna LA; Grunseth AJ; Zagnitko O; Scott DA; Hoang A; Luthra A; Swairjo MA; Schiffer JM; Sohl CD
    Biochem J; 2018 Oct; 475(20):3221-3238. PubMed ID: 30249606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and Characterization of Small-Molecule Inhibitors of the R132H/R132H Mutant Isocitrate Dehydrogenase 1 Homodimer and R132H/Wild-Type Heterodimer.
    Brooks E; Wu X; Hanel A; Nguyen S; Wang J; Zhang JH; Harrison A; Zhang W
    J Biomol Screen; 2014 Sep; 19(8):1193-200. PubMed ID: 24980596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of evidence for substrate channeling or flux between wildtype and mutant isocitrate dehydrogenase to produce the oncometabolite 2-hydroxyglutarate.
    Dexter JP; Ward PS; Dasgupta T; Hosios AM; Gunawardena J; Vander Heiden MG
    J Biol Chem; 2018 Dec; 293(52):20051-20061. PubMed ID: 30381394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of α-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1.
    Kim HJ; Fei X; Cho SC; Choi BY; Ahn HC; Lee K; Seo SY; Keum YS
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5625-31. PubMed ID: 26508549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IDH1 R132H mutation generates a distinct phospholipid metabolite profile in glioma.
    Esmaeili M; Hamans BC; Navis AC; van Horssen R; Bathen TF; Gribbestad IS; Leenders WP; Heerschap A
    Cancer Res; 2014 Sep; 74(17):4898-907. PubMed ID: 25005896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value and limitations of immunohistochemistry and gene sequencing for detection of the IDH1-R132H mutation in diffuse glioma biopsy specimens.
    Preusser M; Wöhrer A; Stary S; Höftberger R; Streubel B; Hainfellner JA
    J Neuropathol Exp Neurol; 2011 Aug; 70(8):715-23. PubMed ID: 21760534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IDH mutations in glioma and acute myeloid leukemia.
    Dang L; Jin S; Su SM
    Trends Mol Med; 2010 Sep; 16(9):387-97. PubMed ID: 20692206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.
    Capper D; Reuss D; Schittenhelm J; Hartmann C; Bremer J; Sahm F; Harter PN; Jeibmann A; von Deimling A
    Acta Neuropathol; 2011 Feb; 121(2):241-52. PubMed ID: 21069360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel multiplex bead-based assay for detection of IDH1 and IDH2 mutations in myeloid malignancies.
    Shivarov V; Ivanova M; Hadjiev E; Naumova E
    PLoS One; 2013; 8(9):e76944. PubMed ID: 24098815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel canine isocitrate dehydrogenase 1 mutation Y208C attenuates dimerization ability.
    Kawakami S; Michishita M; Sakaue M; Morimatsu M; Uemura M; Kashiwagi N; Maeda M; Machida Y; Azakami D; Egusa AS; Onozawa E; Ishioka K; Watanabe M; Tanaka Y; Omi T; Ochiai K
    Oncol Lett; 2020 Dec; 20(6):351. PubMed ID: 33123262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.